<p>Regulatory approval of biosimilars requires a demonstration of comparable clinical efficacy and safety with the reference biologic and the key steps in the process are described here by Professor Irene Krämer.</p>

Regulatory approval of biosimilars requires a demonstration of comparable clinical efficacy and safety with the reference biologic and the key steps in the process are described here by Professor Irene Krämer.

Clinical development of biosimilars and key concepts

Be engaged by the experts through the Hospital Pharmacy Europe podcast series. Editor Andrea Porter and the editorial team speak with pharmacy specialists about key areas of clinical practice and hear how innovative developments are affecting patients within secondary healthcare.

Share Clinical development of biosimilars and key concepts

Sign up to save your podcasts

Clinical development of biosimilars and key concepts

Clinical development of biosimilars and key concepts